• H.B. Fuller recently reported past second-quarter and six-month fiscal 2026 results, with sales of US$950.27 million and US$1.72 billion respectively, alongside higher net income and earnings per share from continuing operations compared with a year earlier.
• In the same period, the company also completed a multi-year share repurchase program totaling 1,397,505 shares for US$89.49 million, underlining its ongoing use of buybacks alongside profit growth.
• Next, we’ll examine how this combination of stronger earnings and completed share repurchases may influence H.B. Fuller’s existing investment narrative.

The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

H.B. Fuller Investment Narrative Recap

To own H.B. Fuller, you need to be comfortable with a steady, margin-focused chemicals business that is balancing growth investments with shareholder returns. The latest quarter’s higher earnings and the completion of its multi-year buyback do not materially change the near term picture, where the key catalyst remains execution on improving profitability while the main risk is still weaker end-market demand and cost inflation pressuring margins and cash generation.

The most relevant update here is the completion of H.B. Fuller’s US$89.49 million share repurchase program, which retired 1,397,505 shares, or 2.56% of the company. Set against recent earnings progress, the buyback adds another piece to the story investors are watching around earnings resilience and balance sheet flexibility, especially given past concerns over elevated net debt to EBITDA and the need to keep funding growth projects.

But even with stronger recent earnings, investors should be aware that higher raw material costs and softer demand in key segments could still...

H.B. Fuller's narrative projects $3.9 billion revenue and $243.6 million earnings by 2029. This requires 4.4% yearly revenue growth and about an $83.8 million earnings increase from $159.8 million today.

Uncover how H.B. Fuller's forecasts yield a $70.43 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Two fair value estimates from the Simply Wall St Community span roughly US$70 to US$90 per share, showing how far apart individual views can be. Against that backdrop, ongoing concerns about market demand softness and input cost pressures give you important context for thinking about how H.B. Fuller might actually perform over time, so it is worth comparing several of these perspectives before deciding what the stock is really worth.

Explore 2 other fair value estimates on H.B. Fuller - why the stock might be worth as much as 42% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your H.B. Fuller research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free H.B. Fuller research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate H.B. Fuller's overall financial health at a glance.

No Opportunity In H.B. Fuller?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Find 44 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 15 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.